These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 15114263)
21. Interference with netrin-1 and tumor cell death in non-small cell lung cancer. Delloye-Bourgeois C; Brambilla E; Coissieux MM; Guenebeaud C; Pedeux R; Firlej V; Cabon F; Brambilla C; Mehlen P; Bernet A J Natl Cancer Inst; 2009 Feb; 101(4):237-47. PubMed ID: 19211441 [TBL] [Abstract][Full Text] [Related]
22. Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice. Vasiljeva O; Korovin M; Gajda M; Brodoefel H; Bojic L; Krüger A; Schurigt U; Sevenich L; Turk B; Peters C; Reinheckel T Oncogene; 2008 Jul; 27(30):4191-9. PubMed ID: 18345026 [TBL] [Abstract][Full Text] [Related]
23. Thyroid influence on the growth of hepatoma HW-165 in Wistar rats. Lemaire M; Baeyens W; de Saint-Georges L; Baugnet-Mahieu L Biomedicine; 1981 Dec; 34(3):133-9. PubMed ID: 7337800 [TBL] [Abstract][Full Text] [Related]
24. Cathepsin B and human tumor progression. Yan S; Sameni M; Sloane BF Biol Chem; 1998 Feb; 379(2):113-23. PubMed ID: 9524062 [TBL] [Abstract][Full Text] [Related]
25. Regression of Morris hepatoma in response to intralesional treatment with tumor necrosis factor muteins. Terlikowski S; Sulkowski S; Nowak HF Eur Cytokine Netw; 1997 Sep; 8(3):259-63. PubMed ID: 9346358 [TBL] [Abstract][Full Text] [Related]
26. [Histopathological changes in rat transplanted hepatoma after lipiodol transarterial embolization]. Jiang B; Lou Q; Ding XF; Sa XY; Chen LR; Yu SY; Chao M Zhonghua Zhong Liu Za Zhi; 2004 Apr; 26(4):205-8. PubMed ID: 15312380 [TBL] [Abstract][Full Text] [Related]
27. A possible application of cathepsin B activity determination for estimating the spread of the cervix uteri carcinoma. Makarewicz R; Drewa G Acta Biochim Pol; 1996; 43(3):521-4. PubMed ID: 8922036 [TBL] [Abstract][Full Text] [Related]
28. RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS Oncogene; 2004 Nov; 23(52):8486-96. PubMed ID: 15378018 [TBL] [Abstract][Full Text] [Related]
29. Overexpression of stefin A in human esophageal squamous cell carcinoma cells inhibits tumor cell growth, angiogenesis, invasion, and metastasis. Li W; Ding F; Zhang L; Liu Z; Wu Y; Luo A; Wu M; Wang M; Zhan Q; Liu Z Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8753-62. PubMed ID: 16361563 [TBL] [Abstract][Full Text] [Related]
30. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice. Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106 [TBL] [Abstract][Full Text] [Related]
31. [Therapeutic effects of recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand on non-small lung cell cancer: an experimental with rats]. Tang YM; Yang SF; Zhu B; Cui JS Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2021-5. PubMed ID: 16313792 [TBL] [Abstract][Full Text] [Related]
32. The importance of determining the aggressiveness of prostate cancer using serum and tissue molecular markers. Kehinde EO; Maghrebi MA; Anim JT Can J Urol; 2008 Apr; 15(2):3967-74. PubMed ID: 18405443 [TBL] [Abstract][Full Text] [Related]
33. [Cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer]. Szajda SD; Darewicz B; Kudelski J; Chlabicz M; Domel T; Chabielska E; Skrzydlewski Z Pol Merkur Lekarski; 2005 Jun; 18(108):651-3. PubMed ID: 16124376 [TBL] [Abstract][Full Text] [Related]
34. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients. Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372 [TBL] [Abstract][Full Text] [Related]
35. Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker. Devetzi M; Scorilas A; Tsiambas E; Sameni M; Fotiou S; Sloane BF; Talieri M Gynecol Oncol; 2009 Mar; 112(3):531-6. PubMed ID: 19110306 [TBL] [Abstract][Full Text] [Related]
36. [Construction of a DNA vaccine against extracellular domain 1-3 of Flk1 and its inhibitory effect on growth of liver cancer cell line H22]. Lu F; Qin ZY; Li YM; Qi YX; Liu YF; Yang WB Ai Zheng; 2004 Dec; 23(12):1616-21. PubMed ID: 15601548 [TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line. Gong ZB; Liu JM; Li YM Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):433-6. PubMed ID: 16109531 [TBL] [Abstract][Full Text] [Related]
38. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice. Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740 [TBL] [Abstract][Full Text] [Related]
39. [Treatment of rabbits bearing advanced VX2 tumors in the mammary gland with nano-sized liposomal adriamycin administered by various routes]. Chen JH; Li Y; Yao Q; Ling R; Wang L; Li KZ; Wang Z; Chen T Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3039-42. PubMed ID: 16324402 [TBL] [Abstract][Full Text] [Related]
40. Treatment of murine tumors using dual-frequency ultrasound in an experimental in vivo model. Barati AH; Mokhtari-Dizaji M; Mozdarani H; Bathaie SZ; Hassan ZM Ultrasound Med Biol; 2009 May; 35(5):756-63. PubMed ID: 19195770 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]